Anxiety Mental and Behavioural Disorders Anxiety disorder, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children aged 5-12 years meeting standard PCAMHS criteria and with anxiety associated with clinical impairment as the primary presenting problem.
Exclusion criteria
Exclusion criteria: 1. Current prescription of psychotropic medication, or if psychotropic medication is prescribed, it should have been at a stable dose for at least 8 weeks prior to the study with agreement to maintain that dose throughout the study. If it is considered that a medication change is needed in the interests of the child, this child will no longer be eligible but will still be able to receive the usual treatment from PCAMHS. 2. The child or parent has a poor understanding of the English language. 3. The child or parent has a known physical or intellectual impairment (including autistic spectrum disorder).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary indicator of recovery is that the child's difficulties with anxiety are 'much' or 'very much' improved on the basis of clinical global impression as assessed post-treatment by an independent assessor, blind to treatment group and trained to a high level of reliability in the use of the measure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety severity is assessed using the ADIS with parent and child and self-report questionnaires of anxiety symptoms, and the impact of anxiety on the child's life. The outcome measure for cost-effectiveness will be the improvement status (much/very much improved), as well as a measure of 'days off school avoided' and generic quality of life as assessed by the child friendly EuroQol EQ-5D and CHU9D-c/p. | — |
Countries
United Kingdom